Paracervical Vasopressin Injection Compared With Intramyometrial Vasopressin in Abdominal Myomectomy

Withdrawn before enrolling · Not applicable

Conditions studied: Myoma

In brief

The goal of the investigators study is to evaluate the effectiveness of paracervical injection of vasopressin at the time of abdominal myomectomy to decrease blood loss. The investigators will continue to use intramyometrial vasopressin as this has previously been shown to be effective. The study will not exceed the safely documented dose of vasopressin.

Key facts

Study ID

NCT02377492

Run by

University Hospitals Cleveland Medical Center

People needed

0

Starts

2015-03-01

Last updated by the study team

2022-05-12

Who can join

Age: 18 and older, up to 60. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Age 18-60 years old
• All women who are candidates for abdominal myomectomy and are willing to accept randomization

You may not qualify if…

• Patients unable to consent for the study
• Suspected malignancy
• History of adverse reaction or allergy to vasopressin
• Active cardiovascular or pulmonary disease that would indicate a contraindication to use of vasopressin

Where it is running

• University Hospitals Fertility Center — Beachwood, Ohio, United States
• University Hospitals — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.